Table 1 Socioeconomic Status and clinical characteristics of patients with CD or UC
CD (N = 1430) | UC (N = 1059) | |||||||
|---|---|---|---|---|---|---|---|---|
Parameters | White | African American | Hispanic | Asian | White | African American | Hispanic | Asian |
N (%) | 1149 (80.3) | 150 (10.5) | 87 (6.1) | 44 (3.1) | 829 (78.3) | 103 (9.7) | 95 (9.0) | 32 (3.0) |
Age at index (mean, SD) | 42.1 (16.6) | 42.8 (17.5) | 40.2 (14.5) | 35.7 (12.1) | 45.5 (17.4) | 44.6 (16.8) | 40.8 (16.9) | 38.7 (13.9) |
Gender, n (%) | ||||||||
Male | 572 (49.8) | 75 (50.0) | 45 (51.7) | 26 (59.1) | 438 (52.8) | 50 (48.5) | 54 (56.8) | 21 (65.6) |
Female | 577 (50.2) | 75 (50.0) | 42 (48.3) | 18 (40.9) | 391 (47.2) | 53 (51.5) | 41 (43.2) | 11 (34.4) |
Region, n (%) | ||||||||
Northeast | 113 (9.8) | 8 (5.3) | 6 (6.9) | 4 (9.1) | 92 (11.1) | 3 (2.9) | 4 (4.2) | 5 (15.6) |
Midwest | 431 (37.5) | 29 (19.3) | 11 (12.6) | 10 (22.7) | 239 (28.8) | 15 (14.6) | 7 (7.4) | 7 (21.9) |
South | 409 (35.6) | 102 (68.0) | 42 (48.3) | 14 (31.8) | 346 (41.7) | 78 (75.7) | 56 (58.9) | 6 (18.8) |
West | 195 (17.0) | 10 (6.7) | 28 (32.2) | 14 (31.8) | 148 (17.9) | 6 (5.8) | 28 (29.5) | 12 (37.5) |
Unknown | 1 (0.1) | 1 (0.7) | 0 (0.0) | 2 (4.5) | 4 (0.5) | 1 (1.0) | 0 (0.0) | 2 (6.3) |
Education level, n (%) | ||||||||
< High school | 165 (14.4) | 56 (37.3) | 24 (27.6) | 4 (9.1) | 125 (15.1) | 35 (34.0) | 21 (22.1) | 1 (3.1) |
< Bachelors | 662 (57.6) | 74 (49.3) | 49 (56.3) | 15 (34.1) | 471 (56.8) | 58 (56.3) | 57 (60.0) | 13 (40.6) |
Bachelors + | 320 (27.9) | 20 (13.3) | 14 (16.1) | 25 (56.8) | 230 (27.7) | 10 (9.7) | 16 (16.8) | 18 (56.3) |
Unknown | 2 (0.2) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 3 (0.4) | 0 (0.0) | 1 (1.1) | 0 (0.0) |
Household income, n (%) | ||||||||
< $40 K | 151 (13.1) | 48 (32.0) | 15 (17.2) | 4 (9.1) | 85 (10.3) | 24 (23.3) | 15 (15.8) | 2 (6.3) |
$40-49 K | 55 (4.8) | 16 (10.7) | 12 (13.8) | 1 (2.3) | 33 (4.0) | 8 (7.8) | 7 (7.4) | 3 (9.4) |
$50-59 K | 66 (5.7) | 18 (12.0) | 3 (3.4) | 0 (0.0) | 57 (6.9) | 8 (7.8) | 7 (7.4) | 2 (6.3) |
$60-79 K | 96 (8.4) | 8 (5.3) | 8 (9.2) | 4 (9.1) | 73 (8.8) | 9 (8.7) | 12 (12.6) | 1 (3.1) |
$75-99 K | 156 (13.6) | 13 (8.7) | 11 (12.6) | 5 (11.4) | 113 (13.6) | 17 (16.5) | 18 (18.9) | 7 (21.9) |
$100 K + | 489 (42.6) | 28 (18.7) | 26 (29.9) | 17 (38.6) | 384 (46.3) | 18 (17.5) | 22 (22.2) | 9 (28.1) |
Unknown | 136 (11.8) | 19 (12.7) | 12 (13.8) | 13 (29.5) | 84 (10.1) | 19 (18.4) | 14 (14.7) | 8 (25.0) |
Housing, n (%) | ||||||||
Homeowner | 814 (70.8) | 86 (57.3) | 47 (54.0) | 24 (54.5) | 633 (76.4) | 56 (54.4) | 64 (67.4) | 15 (46.9) |
Non-homeowner | 102 (8.9) | 29 (19.3) | 20 (23.0) | 2 (4.5) | 66 (8.0) | 16 (15.5) | 11 (11.6) | 6 (18.8) |
Unknown | 233 (20.3) | 35 (23.3) | 20 (23.0) | 18 (40.9) | 130 (15.7) | 31 (30.1) | 20 (21.1) | 11 (34.4) |
Insurance type, n (%) | ||||||||
HMO | 148 (12.9) | 17 (11.3) | 14 (16.1) | 4 (9.1) | 97 (11.7) | 13 (12.6) | 11 (11.6) | 4 (12.5) |
PPO | 30 (2.6) | 10 (6.7) | 1 (1.1) | 2 (4.5) | 19 (2.3) | 3 (2.9) | 1 (1.1) | 2 (6.3) |
POS | 755 (65.7) | 89 (59.3) | 52 (59.8) | 35 (79.5) | 526 (63.4) | 61 (59.2) | 53 (55.8) | 20 (62.5) |
Other | 216 (18.8) | 34 (22.7) | 20 (23.0) | 3 (6.8) | 187 (22.6) | 26 (25.2) | 30 (31.6) | 6 (18.8) |
QCI, mean (SD) | 0.6 (1.2) | 0.7 (1.2) | 0.4 (0.9) | 0.5 (1.0) | 0.7 (1.5) | 1 (1.8) | 0.5 (0.9) | 0.6 (1.4) |
General comorbid conditions, n (%) | ||||||||
Abdominal pain | 724 (63.0) | 97 (64.7) | 58 (66.7) | 32 (72.7) | 449 (54.2) | 55 (53.4) | 55 (57.9) | 12 (25.5) |
Diarrhoea | 534 (46.5) | 65 (43.3) | 43 (49.4) | 18 (40.9) | 558 (67.3) | 63 (61.2) | 54 (56.8) | 18 (38.3) |
Anaemia | 359 (31.2) | 67 (44.7) | 24 (27.6) | 15 (34.1) | 279 (33.7) | 39 (37.9) | 32 (33.7) | 14 (29.8) |
Nausea and vomiting | 328 (28.5) | 63 (42.0) | 27 (31.0) | 12 (27.3) | 178 (21.5) | 22 (21.4) | 21 (22.1) | 3 (6.4) |
Hypertension | 267 (23.2) | 50 (33.3) | 15 (17.2) | 4 (9.1) | 224 (27.0) | 37 (35.9) | 22 (23.2) | 4 (8.5) |
Anxiety | 252 (21.9) | 34 (22.7) | 15 (17.2) | 2 (4.5) | 161 (19.4) | 11 (10.7) | 13 (13.7) | 3 (6.4) |
Hyperlipidemia | 223 (19.4) | 38 (25.3) | 16 (18.4) | 4 (9.1) | 241 (29.1) | 28 (27.2) | 21 (22.1) | 6 (12.8) |
Depression | 197 (17.1) | 24 (16.0) | 8 (9.2) | 5 (11.4) | 106 (12.8) | 8 (7.8) | 12 (12.6) | 2 (4.3) |
Bloating | 112 (9.7) | 14 (9.3) | 12 (13.8) | 4 (9.1) | 68 (8.2) | 6 (5.8) | 10 (10.5) | 2 (4.3) |
Cardiovascular disease | 94 (8.2) | 14 (9.3) | 7 (8.0) | 1 (2.3) | 63 (7.6) | 11 (10.7) | 8 (8.4) | 0 (0.0) |
Diabetes | 87 (7.6) | 17 (11.3) | 8 (9.2) | 1 (2.3) | 85 (10.3) | 16 (15.5) | 10 (10.5) | 2 (4.3) |
Immune-mediated inflammatory diseases, n (%) | ||||||||
Rheumatoid arthritis | 29 (2.5) | 7 (4.7) | 4 (4.6) | 0 (0.0) | 22 (2.7) | 4 (3.9) | 1 (1.1) | 0 (0.0) |
Psoriatic arthritis | 11 (1.0) | 1 (0.7) | 1 (1.1) | 0 (0.0) | 12 (1.4) | 1 (1.0) | 0 (0.0) | 0 (0.0) |
Psoriasis | 38 (3.3) | 4 (2.7) | 1 (1.1) | 0 (0.0) | 21 (2.5) | 2 (1.9) | 0 (0.0) | 0 (0.0) |
Surgery, n (%) | 181 (15.8) | 21 (14.0) | 18 (20.7) | 6 (13.6) | 38 (4.6) | 10 (9.7) | 6 (6.3) | 4 (8.5) |
Medication use, n (%) | ||||||||
Opioids | 594 (51.7) | 81 (54.0) | 45 (51.7) | 16 (36.4) | 345 (41.6) | 42 (40.8) | 29 (30.5) | 14 (29.8) |
Antibiotics | 393 (34.2) | 51 (34.0) | 28 (32.2) | 14 (31.8) | 255 (30.8) | 31 (30.1) | 27 (28.4) | 7 (14.9) |
5-Aminosalicylates | 258 (22.5) | 37 (24.7) | 27 (31.0) | 11 (25.0) | 580 (70.0) | 72 (69.9) | 72 (75.8) | 23 (48.9) |
Steroids | 794 (69.1) | 114 (76.0) | 55 (63.2) | 31 (70.5) | 671 (80.9) | 78 (75.7) | 75 (78.9) | 26 (55.3) |
Immunomodulators | 225 (19.6) | 22 (14.7) | 15 (17.2) | 14 (31.8) | 146 (17.6) | 19 (18.4) | 12 (12.6) | 12 (25.5) |